Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
BRAINTREE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq:MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced it has entered into a collaboration agreement with Corewell Health™. The objective of the collaboration, which will take place in multiple phases, is to enable telerobotics between remote centers by utilizing the LIBERTY Endovascular Robotic Surgical System. The agreement with Corewell Health includes the right to mutually evaluate the LIBERTY System for remote procedures, which will be led by Ryan Madder, M.D., an expert in interventional cardiology.
Related news for (MBOT)
- Midday Market Wrap: Spider Silk Strength, Robotics Surge & Autonomous Acceleration Fuel the Afternoon Trade
- Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
- 24/7 Market News Snapshot 08 September, 2025 – Microbot Medical, Inc. Common Stock (NASDAQ:MBOT)
- MoBot alert highlights: NASDAQ: OCTO, NASDAQ: AREB, NASDAQ: CDT, NASDAQ: ACRV, NASDAQ: MBOT (09/08/25 06:00 AM)
- MoBot alert highlights: NASDAQ: AREB, NASDAQ: CDT, NASDAQ: OCTO, NASDAQ: ACRV, NASDAQ: MBOT (09/08/25 05:00 AM)